Literature DB >> 31754574

Malignant Transformation of Recurrent Synovial Chondromatosis: A Case Report and Review.

John W Urwin1, Kumarasen Cooper2, Ronnie Sebro3.   

Abstract

Chondrosarcoma is the second most common primary malignant bone tumor. While the majority arrive de novo, a minority arise from malignant transformation of benign neoplasms, such as osteochondromas. Rarely, chondrosarcomas have been found to originate from other preexisting lesions, such as synovial chondromatosis. A 44-year-old male with a history of a spinal osteochondroma presented with one year of left hip pain and decreased range of motion. On examination, he had a palpable, irregular fullness in the left groin that was minimally tender to palpation. Radiographs and CT of the hip showed extensive soft tissue calcifications and erosion of the femoral neck. The lesion was debulked surgically and histologically diagnosed as synovial osteochondromatosis with no evidence of atypia or cellularity. One year later, his residual disease progressed and resulted in increasingly limited range of motion. He underwent left total hip arthroplasty with simultaneous debulking and the lesion was once again diagnosed as synovial osteochondromatosis. Two months postoperatively, the patient developed a new focus of calcification around the hip joint that was thought to be recurrent disease. Six months later, due to worsening symptoms, he underwent a repeat CT scan. This scan demonstrated extensive intra-articular disease extending into the iliopsoas bursa and around total hip arthroplasty, as well as a new soft tissue nodule with foci of calcification in the left gluteus maximus. The new lesion was debulked surgically and diagnosed as a grade 1 chondrosarcoma. Chondrosarcoma arising from synovial chondromatosis is a rare presentation of the second most common primary malignant bone tumor. It typically presents as an indolent, slowly growing painful mass of large joints in middle aged men. Conventional radiography shows punctate opacities, while MRI and CT reveal diffuse soft tissue calcification and cortical erosion. Low-grade chondrosarcomas are treated with intralesional curettage and adjuvant therapy, while higher grade chondrosarcomas are treated with wide, en bloc excision. Malignant transformation should be considered in any patient presenting with worsening symptoms and a history of a benign bony lesion.
Copyright © 2019, Urwin et al.

Entities:  

Keywords:  malignant degeneration; synovial chondromatosis

Year:  2019        PMID: 31754574      PMCID: PMC6827705          DOI: 10.7759/cureus.5839

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Chromosome 6 abnormalities are recurrent in synovial chondromatosis.

Authors:  Emilie P Buddingh; Pamela Krallman; James R Neff; Marilu Nelson; Jian Liu; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-01-01

Review 2.  Arthroscopic surgery for synovial chondromatosis of the hip: a systematic review of rates and predisposing factors for recurrence.

Authors:  Darren de Sa; Nolan S Horner; Austin MacDonald; Nicole Simunovic; Michelle A Ghert; Marc J Philippon; Olufemi R Ayeni
Journal:  Arthroscopy       Date:  2014-07-23       Impact factor: 4.772

3.  Synovial chondrosarcoma.

Authors:  Alessio Biazzo; Norberto Confalonieri
Journal:  Ann Transl Med       Date:  2016-08

4.  Dysregulation of hedgehog signalling predisposes to synovial chondromatosis.

Authors:  Sevan Hopyan; Puviindran Nadesan; Chunying Yu; Jay Wunder; Benjamin A Alman
Journal:  J Pathol       Date:  2005-06       Impact factor: 7.996

5.  Arthroscopic management of primary synovial chondromatosis of the hip.

Authors:  Raul Zini; Umile Giuseppe Longo; Massimo de Benedetto; Mattia Loppini; Andrea Carraro; Nicola Maffulli; Vincenzo Denaro
Journal:  Arthroscopy       Date:  2013-01-20       Impact factor: 4.772

6.  Chondrosarcomas of the synovium.

Authors:  F Bertoni; K K Unni; J W Beabout; F H Sim
Journal:  Cancer       Date:  1991-01-01       Impact factor: 6.860

Review 7.  The clinical approach towards chondrosarcoma.

Authors:  Hans Gelderblom; Pancras C W Hogendoorn; Sander D Dijkstra; Carla S van Rijswijk; Augustinus D Krol; Antonie H M Taminiau; Judith V M G Bovée
Journal:  Oncologist       Date:  2008-03

Review 8.  Synovial osteochondromatosis.

Authors:  J M Crotty; J U Monu; T L Pope
Journal:  Radiol Clin North Am       Date:  1996-03       Impact factor: 2.303

9.  Transforming growth factor beta 3 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint.

Authors:  Yingjie Li; Loaye Abdelaziz El Mozen; Hengxing Cai; Wei Fang; Qinggong Meng; Jian Li; Mohong Deng; Xing Long
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

10.  Synovial chondromatosis and chondrosarcoma: a diagnostic dilemma.

Authors:  Brita L Sperling; Steven Angel; Grant Stoneham; Vance Chow; Andrew McFadden; Rajni Chibbar
Journal:  Sarcoma       Date:  2003
View more
  1 in total

1.  Clinical comparison of tenosynovial giant cell tumors, synovial chondromatosis, and synovial sarcoma: analysis and report of 53 cases.

Authors:  Wei Wang; Man-Mei Long; Cheng-Jiang Wei; Xi-Wei Cui; Jie-Yi Ren; Yi-Hui Gu; Qing-Feng Li; Shun-Dong Dai; Bin Gu; Zhi-Chao Wang
Journal:  Ann Transl Med       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.